Metabolism of tissue macrophages in homeostasis and pathology

SK Wculek, G Dunphy, I Heras-Murillo… - Cellular & molecular …, 2022 - nature.com
Cellular metabolism orchestrates the intricate use of tissue fuels for catabolism and
anabolism to generate cellular energy and structural components. The emerging field of …

Alveolar lipids in pulmonary disease. A review

CW Agudelo, G Samaha, I Garcia-Arcos - Lipids in health and disease, 2020 - Springer
Lung lipid metabolism participates both in infant and adult pulmonary disease. The lung is
composed by multiple cell types with specialized functions and coordinately acting to meet …

Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis

SK Wculek, I Heras-Murillo, A Mastrangelo, D Mañanes… - Immunity, 2023 - cell.com
In vitro studies have associated oxidative phosphorylation (OXPHOS) with anti-inflammatory
macrophages, whereas pro-inflammatory macrophages rely on glycolysis. However, the …

Systemic juvenile idiopathic arthritis–associated lung disease: characterization and risk factors

GS Schulert, S Yasin, B Carey, C Chalk… - Arthritis & …, 2019 - Wiley Online Library
Objective Systemic juvenile idiopathic arthritis (JIA) is associated with a recently recognized,
albeit poorly defined and characterized, lung disease (LD). The objective of this study was to …

The significance of SPP1 in lung cancers and its impact as a marker for protumor tumor-associated macrophages

E Matsubara, H Yano, C Pan, Y Komohara, Y Fujiwara… - Cancers, 2023 - mdpi.com
Simple Summary Macrophages that infiltrate the cancer microenvironment are referred to as
tumor-associated macrophages (TAMs). Phosphoprotein 1 (SPP1), also known as …

Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol

SY Jiang, H Li, JJ Tang, J Wang, J Luo, B Liu… - Nature …, 2018 - nature.com
Statins are inhibitors of HMG-CoA reductase, the rate-limiting enzyme of cholesterol
biosynthesis, and have been clinically used to treat cardiovascular disease. However, a …

Pulmonary alveolar proteinosis

BC Trapnell, K Nakata, F Bonella, I Campo… - Nature Reviews …, 2019 - nature.com
Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by the accumulation of
alveolar surfactant and dysfunction of alveolar macrophages. PAP results in progressive …

[HTML][HTML] Human inherited CCR2 deficiency underlies progressive polycystic lung disease

AL Neehus, B Carey, M Landekic, P Panikulam… - Cell, 2024 - cell.com
We describe a human lung disease caused by autosomal recessive, complete deficiency of
the monocyte chemokine receptor CC motif chemokine receptor 2 (CCR2). Nine children …

Autoimmune pulmonary alveolar proteinosis

C McCarthy, BC Carey, BC Trapnell - American journal of …, 2022 - atsjournals.org
Autoimmune pulmonary alveolar proteinosis (PAP) is a rare disease characterized by
myeloid cell dysfunction, abnormal pulmonary surfactant accumulation, and innate immune …

[HTML][HTML] Development and functions of alveolar macrophages

YD Woo, D Jeong, DH Chung - Molecules and cells, 2021 - Elsevier
Macrophages residing in various tissue types are unique in terms of their anatomical
locations, ontogenies, developmental pathways, gene expression patterns, and …